Acorn Wealth Advisors, LLC Gilead Sciences, Inc. Transaction History

Acorn Wealth Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	SELL	$57.92 - $72.58 $162,986 - $204,240	-2,814 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $182,572 - $207,222	2,814 New	2,814 $204,000
Q4 2018 Feb 04, 2019	SELL	$60.54 - $79.0 $283,206 - $369,562	-4,678 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $71 - $78	-1 Reduced 0.02%	4,678 $328,000
Q2 2018 Aug 10, 2018	BUY	$64.88 - $75.68 $4,671 - $5,448	72 Added 1.56%	4,679 $334,000
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $3,642 - $4,440	-50 Reduced 1.07%	4,607 $340,000
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $331,345 - $388,952	4,657	4,657 $345,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Acorn Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Acorn Wealth Advisors, LLC with notifications on news.